TY - JOUR
T1 - Optimizing gene panels for equitable reproductive carrier screening
T2 - The Goldilocks approach
AU - Gruzin, Mia J.
AU - Hobbs, Matthew
AU - Ellsworth, Rachel E.
AU - Poll, Sarah
AU - Aguilar, Sienna
AU - Knezovich, Jaysen
AU - Faulkner, Nicole
AU - Olsen, Nick
AU - Aradhya, Swaroop
AU - Burnett, Leslie
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/6
Y1 - 2025/6
N2 - Purpose: Professional organizations recommend pan-ancestry carrier screening for autosomal recessive and X-linked conditions. Advances in DNA sequencing have allowed the analysis of hundreds of genes; however, the optimal number of genes for carrier screening remains unclear. The American College of Medical Genetics and Genomics (ACMG) has proposed a tiered approach recommending screening for 113 genes. Methods: We analyzed ClinVar and gnomAD v4.1.0, for genes associated with serious autosomal recessive and X-linked conditions and modeled screening performance across panels of varying compositions and sizes in diverse genetic ancestries. We also reevaluated the ACMG gene list using the updated gnomAD data. Results: We identified potential inconsistencies in the ACMG gene lists, particularly in the carrier test performance (defined as a positive yield) for underrepresented genetic ancestry groups. Modeling of the population data for 1310 genes revealed that the screening of 152, 248, 531, and 725 genes achieved 90%, 95%, 99%, and 99.7% positive yields, respectively, in couples. Real-world data from the screening of more than 60,000 couples were used to validate the model. Conclusion: Our methodology optimizes the gene content of carrier screening panels for diverse ancestry groups, provides a mechanism for continually updating guidelines, ensures consistency with genomic population data, and improves equity across populations.
AB - Purpose: Professional organizations recommend pan-ancestry carrier screening for autosomal recessive and X-linked conditions. Advances in DNA sequencing have allowed the analysis of hundreds of genes; however, the optimal number of genes for carrier screening remains unclear. The American College of Medical Genetics and Genomics (ACMG) has proposed a tiered approach recommending screening for 113 genes. Methods: We analyzed ClinVar and gnomAD v4.1.0, for genes associated with serious autosomal recessive and X-linked conditions and modeled screening performance across panels of varying compositions and sizes in diverse genetic ancestries. We also reevaluated the ACMG gene list using the updated gnomAD data. Results: We identified potential inconsistencies in the ACMG gene lists, particularly in the carrier test performance (defined as a positive yield) for underrepresented genetic ancestry groups. Modeling of the population data for 1310 genes revealed that the screening of 152, 248, 531, and 725 genes achieved 90%, 95%, 99%, and 99.7% positive yields, respectively, in couples. Real-world data from the screening of more than 60,000 couples were used to validate the model. Conclusion: Our methodology optimizes the gene content of carrier screening panels for diverse ancestry groups, provides a mechanism for continually updating guidelines, ensures consistency with genomic population data, and improves equity across populations.
KW - ACMG
KW - Carrier screening
KW - Equity
KW - Pan-ancestry
KW - Reproductive genetics
UR - http://www.scopus.com/inward/record.url?scp=105004185749&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2025.101387
DO - 10.1016/j.gim.2025.101387
M3 - Article
C2 - 40084622
AN - SCOPUS:105004185749
SN - 1098-3600
VL - 27
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 6
M1 - 101387
ER -